Mankind Pharma Limited — Others, 31-07-2025: Monitoring Agency Report

Mankind Pharma has released its QIP utilization report for the quarter ended June 30, 2025. The company's Audit Committee and Board have reviewed the report from Care Ratings Limited. It confirms that the entire Rs. 3,000 Cr raised through the Qualified Institutional Placement has been fully utilized as planned. There is no deviation from the stated objects, which included repayment of Commercial Paper Series I (Rs. 2900.03 Cr), General Corporate Purposes (Rs. 55 Cr), and issue expenses (Rs. 44.97 Cr). This indicates transparent and efficient use of funds, positively impacting the company's financial health.